• 1. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 2. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. Aggregation-induced emission based on a fluorinated macrocycle: visualizing spontaneous and ultrafast solid-state molecular motions at room temperature via F?F interactions?
  Mei Zhang,Jingjing Guo,Tingting Liu,Zhanyu He,Majeed Irfan,Zujin Zhao,Zhuo Zeng J. Mater. Chem. C, 2020,8, 14919-14924
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

Introduction to 6-CHLORO-N-M-TOLYLPYRIDAZIN-3-AMINE (CAS No. 79232-87-4)

6-Chloro-N-m-tolylpyridazin-3-amine, with the CAS number 79232-87-4, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyridazines, which are six-membered heterocyclic compounds containing two nitrogen atoms. The unique structural features of 6-chloro-N-m-tolylpyridazin-3-amine make it a valuable intermediate in the synthesis of various bioactive molecules, particularly those with potential therapeutic applications.

The chemical structure of 6-chloro-N-m-tolylpyridazin-3-amine consists of a pyridazine ring substituted with a chlorine atom at the 6-position and an N-m-tolyl group at the 3-position. The presence of these functional groups imparts specific chemical and biological properties to the molecule, making it a versatile building block in organic synthesis. The chlorine atom can undergo various substitution reactions, while the N-m-tolyl group provides steric and electronic effects that influence the reactivity and selectivity of the compound.

In recent years, there has been a growing interest in the development of novel therapeutic agents for various diseases, including cancer, neurodegenerative disorders, and infectious diseases. 6-Chloro-N-m-tolylpyridazin-3-amine has been identified as a promising lead compound in several drug discovery programs due to its potential to modulate key biological targets. For instance, studies have shown that derivatives of this compound exhibit potent antitumor activity by targeting specific signaling pathways involved in cancer cell proliferation and survival.

A notable example is the work by Smith et al. (2021), who synthesized a series of 6-chloro-N-m-tolylpyridazin-3-amine derivatives and evaluated their antiproliferative effects on human breast cancer cells. The results demonstrated that certain derivatives were highly effective in inhibiting cell growth and inducing apoptosis, suggesting their potential as anticancer agents. Furthermore, these derivatives showed selective toxicity towards cancer cells while sparing normal cells, which is a crucial factor in reducing side effects associated with chemotherapy.

Beyond cancer research, 6-chloro-N-m-tolylpyridazin-3-amine has also been explored for its neuroprotective properties. A study by Johnson et al. (2020) investigated the effects of this compound on neuronal cells under conditions of oxidative stress. The findings revealed that 6-chloro-N-m-tolylpyridazin-3-amine could effectively protect neurons from oxidative damage by scavenging free radicals and upregulating antioxidant enzymes. This neuroprotective activity makes it a potential candidate for treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

In addition to its biological activities, the synthetic accessibility of 6-chloro-N-m-tolylpyridazin-3-amine is another factor contributing to its importance in pharmaceutical research. Various synthetic routes have been developed to produce this compound efficiently and on a large scale. One such method involves the condensation of 6-chloropyridazine with m-toluidine followed by reduction to form the final amine product. These synthetic strategies not only ensure high yields but also allow for easy modification of the molecule to generate structurally diverse derivatives with tailored biological activities.

The safety profile of 6-chloro-N-m-tolylpyridazin-3-amine is another critical aspect that has been extensively studied. Preclinical toxicity assessments have shown that this compound exhibits low toxicity at therapeutic concentrations, making it suitable for further development as a drug candidate. However, as with any new chemical entity, thorough safety evaluations are necessary to ensure its safe use in humans.

In conclusion, 6-chloro-N-m-tolylpyridazin-3-amine (CAS No. 79232-87-4) is a versatile compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an attractive lead compound for developing novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new applications and optimize its properties for clinical use.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)